The abnormal aggregation of Tau proteins is an important pathogenic factor leading to Alzheimer’s disease (AD), and the pathological burden caused by Tau aggregates has been highly correlated with the severity of cognitive impairment [1,2]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.